Next-generation gene therapy demonstrates best-in-class potential with majority of neurons transduced in substantia nigra and high levels of GCase supplementation after single IV infusion Broad GCase elevation achieved in NHPs, while significantly detargeting the...
PET imaging scans demonstrated evidence of the engrafted cells surviving in both the low- and high-dose cohorts. (iStock / Getty Images Plus) Things are continuing to look up for Bayer’s Parkinson’s disease cell therapy, with the German pharma giant finally offering a...
